Healthcare
Monday, December 5, 2016
BRIEF-Beigene presents updated clinical data on BTK Inhibitor BGB-3111 in CLL, SLL patients
* Beigene presents updated clinical data on BTK Inhibitor
BGB-3111 in patients with chronic lymphocytic leukemia and small
lymphocytic leukemia at the 2016 American Society Of Hematology
Annual Meeting
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment